Knockdown of Ubiquitin-Conjugating Enzyme E2T (UBE2T) Suppresses Lung Adenocarcinoma Progression via Targeting Fibulin-5 (FBLN5)

UBE2T may be a potential biomarker of lung adenocarcinoma (LUAD), and targeting the UBE2T/FBLN5 axis may be a novel treatment strategy for LUAD.